We are live on ! Find out more
PALI icon

Palisade Bio
PALI

96 hedge funds and large institutions have $262M invested in Palisade Bio in 2026 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 20

20% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 25

12% more funds holding

Funds holding: 86 → 96 (+10)

1.07% less ownership

Funds ownership: 91.19% → 90.12% (-1.1%)

18% less capital invested

Capital invested by funds: $319M → $262M (-$57.6M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
96
Holders Change
+10
Holders Change %
+11.63%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
31
Increased
30
Reduced
25
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BGI
B Group Inc
Texas
+$12.6M
2
Goldman Sachs
Goldman Sachs
New York
+$8.76M
3
Ameriprise
Ameriprise
Minnesota
+$8.36M
4
GPP
Great Point Partners
Connecticut
+$6.19M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$5.7M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$18.3M
2
SC
Stempoint Capital
New York
-$9.85M
3
CC
Commodore Capital
New York
-$7.75M
4
PA
Perceptive Advisors
New York
-$5.68M
5
VC
Vivo Capital
California
-$5.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
QC
101
Quadrature Capital
United Kingdom
– -$565K -240,586 Closed
Susquehanna International Group
102
Susquehanna International Group
Pennsylvania
– -$500K -212,659 Closed
SRL
103
Scientech Research LLC
New Jersey
– -$497K -211,441 Closed
TD Asset Management
104
TD Asset Management
Ontario, Canada
– -$480K -204,448 Closed
DP
105
Diadema Partners
New Jersey
– -$390K -166,049 Closed
Manulife (Manufacturers Life Insurance)
106
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$252K -106,636 Closed
SCM
107
Silverarc Capital Management
Massachusetts
– -$240K -102,108 Closed
VEA
108
Virtus ETF Advisers
New York
– -$108K -46,000 Closed
LIP
109
Lighthouse Investment Partners
Florida
– -$92.8K -39,480 Closed
AI
110
Atom Investors
Texas
– -$33K -14,041 Closed
VF
111
Virtu Financial
New York
– -$28K -11,870 Closed
FDCDDQ
112
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$235 -100 Closed
SWM
113
SHP Wealth Management
Massachusetts
– -$118 -50 Closed
Wells Fargo
114
Wells Fargo
California
– -$49 -21 Closed
Fidelity Investments
115
Fidelity Investments
Massachusetts
– -$24 -10 Closed
1 2 3 4
5

PALI Hedge Fund Activity: Q1 2026 in Review

96 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q1 2026, worth a combined $262M — down 18% from $319M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PALI positions and 20 closed out — a net gain of 11 holders — while 30 added to existing stakes and 25 trimmed.

The largest buyer was B Group Inc, adding an estimated $12.6M. The largest seller was Point72 Asset Management, cutting an estimated $18.3M.

  • 96 institutional investors held Palisade Bio (PALI) as of Q1 2026, up from 86 in Q4 2025.
  • Funds reported $262M of Palisade Bio stock for Q1 2026, down 18% quarter-over-quarter.
  • 31 funds opened new Palisade Bio positions in Q1 2026 and 20 closed out, a net change of +11 holders.
  • The largest Palisade Bio buyer in Q1 2026 was B Group Inc, an estimated $12.6M added.
  • The largest Palisade Bio seller in Q1 2026 was Point72 Asset Management, an estimated $18.3M sold.

Based on aggregated 13F filings for Q1 2026.